Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study
Introduction: Previous studies show encouraging oncologic outcomes for neoadjuvant chemotherapy (NACT) in the setting of pancreatic ductal adenocarcinoma (PDAC). However, recent literature reported an increased clinical burden in patients undergoing pancreaticoduodenectomy (PD) following NACT. There...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2019-11-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01299/full |
| _version_ | 1828784011708727296 |
|---|---|
| author | Nicolò Pecorelli Michele Pagnanelli Lorenzo Cinelli Francesca Di Salvo Stefano Partelli Stefano Partelli Stefano Crippa Stefano Crippa Domenico Tamburrino Renato Castoldi Giulio Belfiori Michele Reni Massimo Falconi Massimo Falconi Gianpaolo Balzano |
| author_facet | Nicolò Pecorelli Michele Pagnanelli Lorenzo Cinelli Francesca Di Salvo Stefano Partelli Stefano Partelli Stefano Crippa Stefano Crippa Domenico Tamburrino Renato Castoldi Giulio Belfiori Michele Reni Massimo Falconi Massimo Falconi Gianpaolo Balzano |
| author_sort | Nicolò Pecorelli |
| collection | DOAJ |
| description | Introduction: Previous studies show encouraging oncologic outcomes for neoadjuvant chemotherapy (NACT) in the setting of pancreatic ductal adenocarcinoma (PDAC). However, recent literature reported an increased clinical burden in patients undergoing pancreaticoduodenectomy (PD) following NACT. Therefore, the aim of our study was to assess the impact of NACT on postoperative outcomes and recovery after PD.Methods: A retrospective propensity score-matched study was performed including all patients who underwent PD for PDAC in a single center between 2015 and 2018. Patients treated with NACT for resectable, borderline resectable or locally advanced PDAC were matched based on nearest neighbor propensity scores in a 1:1 ratio to patients who underwent upfront resection. Propensity scores were calculated using 7 perioperative variables, including gender, age, BMI, ASA score, Charlson-Deyo comorbidity score, fistula risk score (FRS), vascular resection. Primary outcome was the number and severity of complications at 90-days after surgery measured by the comprehensive complication index (CCI). Data are reported as median (IQR) or number of patients (%).Results: Of 283 resected patients, 95 (34%) were treated with NACT. Before matching, NACT patients were younger, had less comorbidities (Charlson-Deyo score 0 vs. 1, p = 0.04), similar FRS [2 (0–3) for both groups], and more vascular resections performed [n = 28 (30%) vs. n = 26 (14%), p < 0.01]. After propensity-score matching, preoperative and intraoperative characteristics were comparable. Postoperatively, CCI was similar between groups [8.7 (0–29.6) for both groups, p = 0.59]. NACT patients had a non-statistically significant increase in superficial incisional surgical site infections [n = 12 (13%) vs. 6 (6%), p = 0.14], while no difference was found for overall infectious complications and organ-space SSI. The occurrence of clinically-relevant pancreatic fistula was similar between groups [10 (11%) vs. 13 (14%), p = 0.51]. No difference was found between groups for length of hospital stay [8 (7–15) vs. 8 (7–14) days, p = 0.62], and functional recovery outcomes.Conclusion: After propensity score adjustment for perioperative risk factors, NACT did not worsen postoperative outcomes and functional recovery following PD for PDAC compared to upfront resection. |
| first_indexed | 2024-12-11T23:23:41Z |
| format | Article |
| id | doaj.art-6fea810209994acb948824fe66c5b63d |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-11T23:23:41Z |
| publishDate | 2019-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-6fea810209994acb948824fe66c5b63d2022-12-22T00:46:17ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2019-11-01910.3389/fonc.2019.01299489878Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched StudyNicolò Pecorelli0Michele Pagnanelli1Lorenzo Cinelli2Francesca Di Salvo3Stefano Partelli4Stefano Partelli5Stefano Crippa6Stefano Crippa7Domenico Tamburrino8Renato Castoldi9Giulio Belfiori10Michele Reni11Massimo Falconi12Massimo Falconi13Gianpaolo Balzano14Division of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, ItalyVita-Salute San Raffaele University, Milan, ItalyVita-Salute San Raffaele University, Milan, ItalyDivision of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, ItalyDivision of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, ItalyVita-Salute San Raffaele University, Milan, ItalyDivision of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, ItalyVita-Salute San Raffaele University, Milan, ItalyDivision of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, ItalyDivision of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, ItalyDivision of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, ItalyDepartment of Medical Oncology, San Raffaele Scientific Institute, Milan, ItalyDivision of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, ItalyVita-Salute San Raffaele University, Milan, ItalyDivision of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, ItalyIntroduction: Previous studies show encouraging oncologic outcomes for neoadjuvant chemotherapy (NACT) in the setting of pancreatic ductal adenocarcinoma (PDAC). However, recent literature reported an increased clinical burden in patients undergoing pancreaticoduodenectomy (PD) following NACT. Therefore, the aim of our study was to assess the impact of NACT on postoperative outcomes and recovery after PD.Methods: A retrospective propensity score-matched study was performed including all patients who underwent PD for PDAC in a single center between 2015 and 2018. Patients treated with NACT for resectable, borderline resectable or locally advanced PDAC were matched based on nearest neighbor propensity scores in a 1:1 ratio to patients who underwent upfront resection. Propensity scores were calculated using 7 perioperative variables, including gender, age, BMI, ASA score, Charlson-Deyo comorbidity score, fistula risk score (FRS), vascular resection. Primary outcome was the number and severity of complications at 90-days after surgery measured by the comprehensive complication index (CCI). Data are reported as median (IQR) or number of patients (%).Results: Of 283 resected patients, 95 (34%) were treated with NACT. Before matching, NACT patients were younger, had less comorbidities (Charlson-Deyo score 0 vs. 1, p = 0.04), similar FRS [2 (0–3) for both groups], and more vascular resections performed [n = 28 (30%) vs. n = 26 (14%), p < 0.01]. After propensity-score matching, preoperative and intraoperative characteristics were comparable. Postoperatively, CCI was similar between groups [8.7 (0–29.6) for both groups, p = 0.59]. NACT patients had a non-statistically significant increase in superficial incisional surgical site infections [n = 12 (13%) vs. 6 (6%), p = 0.14], while no difference was found for overall infectious complications and organ-space SSI. The occurrence of clinically-relevant pancreatic fistula was similar between groups [10 (11%) vs. 13 (14%), p = 0.51]. No difference was found between groups for length of hospital stay [8 (7–15) vs. 8 (7–14) days, p = 0.62], and functional recovery outcomes.Conclusion: After propensity score adjustment for perioperative risk factors, NACT did not worsen postoperative outcomes and functional recovery following PD for PDAC compared to upfront resection.https://www.frontiersin.org/article/10.3389/fonc.2019.01299/fullpancreatic cancerneoadjuvant treatmentpancreaticoduodenectomypostoperative complicationsfunctional recovery |
| spellingShingle | Nicolò Pecorelli Michele Pagnanelli Lorenzo Cinelli Francesca Di Salvo Stefano Partelli Stefano Partelli Stefano Crippa Stefano Crippa Domenico Tamburrino Renato Castoldi Giulio Belfiori Michele Reni Massimo Falconi Massimo Falconi Gianpaolo Balzano Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study Frontiers in Oncology pancreatic cancer neoadjuvant treatment pancreaticoduodenectomy postoperative complications functional recovery |
| title | Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study |
| title_full | Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study |
| title_fullStr | Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study |
| title_full_unstemmed | Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study |
| title_short | Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study |
| title_sort | postoperative outcomes and functional recovery after preoperative combination chemotherapy for pancreatic cancer a propensity score matched study |
| topic | pancreatic cancer neoadjuvant treatment pancreaticoduodenectomy postoperative complications functional recovery |
| url | https://www.frontiersin.org/article/10.3389/fonc.2019.01299/full |
| work_keys_str_mv | AT nicolopecorelli postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT michelepagnanelli postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT lorenzocinelli postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT francescadisalvo postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT stefanopartelli postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT stefanopartelli postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT stefanocrippa postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT stefanocrippa postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT domenicotamburrino postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT renatocastoldi postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT giuliobelfiori postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT michelereni postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT massimofalconi postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT massimofalconi postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy AT gianpaolobalzano postoperativeoutcomesandfunctionalrecoveryafterpreoperativecombinationchemotherapyforpancreaticcancerapropensityscorematchedstudy |